Days Sales in Receivables: The average number of days it takes to collect outstanding receivable amounts from customers. Calculated as: Number of Days in Period / Receivable Turnover
Bio-Rad Laboratories, Inc. (BIO) had Days Sales in Receivables of 64.78 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$592.10M |
|
$-527.10M |
|
$282.70M |
|
$309.40M |
|
$558.00M |
|
$34.10M |
|
$-723.90M |
|
$-689.80M |
|
$48.40M |
|
$-527.10M |
|
$-527.10M |
|
$-527.10M |
|
$385.22M |
|
$34.10M |
|
$34.10M |
|
26.96M |
|
26.96M |
|
$-19.55 |
|
$-19.55 |
|
| Balance Sheet Financials | |
$2.94B |
|
$527.50M |
|
$6.85B |
|
$9.79B |
|
$917.00M |
|
$802.90M |
|
$2.02B |
|
$2.94B |
|
$6.85B |
|
$6.11B |
|
$6.85B |
|
26.83M |
|
| Cash Flow Statement Financials | |
$108.10M |
|
$-93.20M |
|
$-44.00M |
|
$532.20M |
|
$509.00M |
|
$-23.20M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.21 |
|
-- |
|
-- |
|
0.10 |
|
0.18 |
|
52.25% |
|
5.76% |
|
5.76% |
|
-- |
|
-116.50% |
|
-89.02% |
|
$78.20M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
0.37 |
|
1.39 |
|
|
Days Sales in Receivables |
64.78 |
-7.69% |
|
-8.63% |
|
-5.38% |
|
-6.89% |
|
$255.38 |
|
$2.90 |
|
$4.01 |
|